Treatment of Burkitt lymphoma in adults Journal Article


Authors: Gerecitano, J.; Straus, D. J.
Article Title: Treatment of Burkitt lymphoma in adults
Abstract: Since its initial description in 1958, Burkitt lymphoma has become a prototype for our understanding of the pathogenesis and optimal treatment of aggressive lymphomas. The evolution of the treatment of this disease is explored and current therapeutic approaches evaluated. Special issues in the treatment of Burkitt lymphoma will also be discussed, including considerations in patients infected with HIV and current views on prophylactic measures and treatment of tumor lysis syndrome. © 2006 Future Drugs Ltd.
Keywords: adult; prednisone; clinical trial; disease course; pathogenesis; review; cytotoxic agent; doxorubicin; cancer combination chemotherapy; pathophysiology; cytarabine; methotrexate; human immunodeficiency virus infection; antineoplastic agent; etoposide; antineoplastic combined chemotherapy protocols; cyclophosphamide; dexamethasone; vincristine; stem cell transplantation; age factors; cancer therapy; ifosfamide; central nervous system tumor; age; virology; hyperuricemia; tumor lysis syndrome; folinic acid; bleomycin; cancer relapse; antiretrovirus agent; highly active antiretroviral therapy; burkitt lymphoma; hiv infections; allopurinol; aggressive lymphoma; human immunodeficiency virus infected patient; rasburicase; codox-m-ivac; xanthine oxidase inhibitor
Journal Title: Expert Review of Anticancer Therapy
Volume: 6
Issue: 3
ISSN: 1473-7140
Publisher: Taylor & Francis Group  
Date Published: 2006-03-01
Start Page: 373
End Page: 381
Language: English
PUBMED: 16503854
PROVIDER: scopus
DOI: 10.1586/14737140.6.3.373
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 4 June 2012" - "CODEN: ERATB" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David J Straus
    356 Straus
Related MSK Work